Pemvidutide vs Efinopegdutide

Head-to-head comparison of Pemvidutide (Pemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) and Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyPemvidutideEfinopegdutide
CategoryWeight ManagementWeight Management
Full NamePemvidutide (ALT-801), long-acting glucagon-like peptide-1/glucagon receptor dual agonistEfinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist
Molecular WeightN/AN/A
Half-LifeApproximately 1 weekApproximately 1 week
Amino AcidsN/AN/A
Typical DoseTrial-dependent; once-weekly SC titrationTrial-dependent; weekly SC dosing
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count1814
Research StatusClinicalClinical

Pemvidutide Benefits

  • appetite suppression
  • body-weight reduction
  • improved liver-fat markers
  • better glycemic control

Efinopegdutide Benefits

  • reduced body weight
  • improved insulin sensitivity
  • reduced liver fat
  • greater satiety

Pemvidutide Dosing

once-weekly subcutaneous injection|gradual dose escalation|maintenance at tolerated trial dose

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

Pemvidutide Side Effects

  • nausea
  • vomiting
  • diarrhea

Efinopegdutide Side Effects

  • nausea
  • decreased appetite
  • fatigue

Research Overview

Pemvidutide

Clinical studies have reported dose-dependent weight loss and favorable effects on liver fat and transaminases. It remains investigational and is not approved for obesity treatment.

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Pemvidutide stacks with:

metformintopiramate

Efinopegdutide stacks with:

metforminorlistat
glp1glucagondual-agonistobesitymashnash